2017 American Transplant Congress
Lower Rates of Living Donation Among Transplant Centers Located in the Stroke Belt.
University of Alabama at Birmingham, Birmingham
Background: The prevalence of comorbid disease continues to increase in the United States, particularly in areas like the Stroke Belt, but it is unknown whether…2017 American Transplant Congress
Vendor to Center in 0-60: A Safe and Effective Blueprint for Creating an In-House On-Call System for Organ Offers.
Transplant, Medical University of South Carolina, Charleston, SC
Introduction: Our center returned to an in-house nurse coordinator on-call program 7/2016 after using a vendor from 11/2012 to 7/2016 for organ allocation. It was…2017 American Transplant Congress
Evolution of Health Related Quality of Life (HRQOL) in Kidney Donors.
1U of MN, Mpls; 2M Health, Mpls
Most living donors (LDs) enjoy excellent HRQOL after donation. However, most studies addressing HRQOL in this group have ascertained HRQOL related outcomes only at one…2017 American Transplant Congress
Predicting Residual Renal Compensation in Living Kidney Donors Post-Donation.
Ohio State University College of Medicine, Columbus, OH
In living kidney donors it is well established that post-donation the remaining kidney undergoes functional hypertrophy; resulting in a 20% – 40% in increase in…2017 American Transplant Congress
ABO Incompatible Deceased Donor Renal Transplantation: Exploring the Possibilities.
Background: There is significant variation in waiting times for deceased donor (DD) renal transplants based on recipient blood group. Furthermore, there is an increased discard…2017 American Transplant Congress
The Association of Donor Vasoactive Drugs with Pancreas Transplant Graft Survival.
Introduction: Vasoactive drugs (VaD) are commonly used to correct abnormal haemodynamics of organ donors in Intensive Care Units (ICU). VaDs can differentially affect insulin secretion…2017 American Transplant Congress
Predictors of Renal Function Compensation in Live Donor Nephrectomy.
Introduction: Renal transplantation is the preferred option for patients with end stage renal disease (ESRD). It provides better quality of life and lower mortality rates…2017 American Transplant Congress
The Cumulative United States Experience with Transplants (Txs) from Living Donors (LDs): 140,156 LD Txs in 28 Years.
Background/Purpose: Solid organ txs from LDs provide better outcome results than from DDs. We analyzed the cumulative US LD tx experience since UNOS inception. The…2017 American Transplant Congress
When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.
Purpose: No studies for any type of surgery have examined learning curves beyond a decade or 100 cases because surgeon turnover and lack of complete…2017 American Transplant Congress
Influence of an Enhanced Recovery Protocol in Laparoscopic Living Donor Nephrectomy.
Surgery, Duke University Medical Center, Durham, NC
Background/Introduction: Enhanced recovery programs (ERPs) in colorectal surgery have decreased the duration of postoperative ileus and hospital stay while showing equivalent morbidity, mortality and readmission…
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 90
- Next Page »